ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.119,94
1,10%
Dow Jones
38.642,34
1,09%
Euro vs US Dollar
1,07665
0,34%
Bitcoin
61.669,47
4,31%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Collegium Pharmaceutical Inc (COLL)

  7. Collegium Pharmaceutical Inc (COLL) News

COLL Collegium Pharmaceutical Inc

37,655
0,145 (0,39%)
Zuletzt aktualisiert: 18:42:04
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Collegium Pharmaceutical Inc COLL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,145 0,39% 37,655 18:42:04
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
37,80 37,48 38,32 37,51
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202414:00GLOBECollegium Announces Authorized Generic Agreement with Hikma..
25.4.202414:00GLOBECollegium to Report First Quarter 2024 Financial Results on..
11.4.202414:00GLOBECollegium Pharmaceutical, Inc. Announces Redemption of..
03.4.202414:00GLOBECollegium to Participate in 23rd Annual Needham Virtual..
04.3.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:24EDGAR2Form 144 - Report of proposed sale of securities
26.2.202422:39EDGAR2Form 144 - Report of proposed sale of securities
22.2.202422:09GLOBECollegium Reports Record Fourth Quarter and Full-Year 2023..
22.2.202422:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202422:01EDGAR2Form 8-K - Current report
14.2.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202418:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202414:00GLOBECollegium to Report Fourth Quarter and Full-Year 2023..
18.1.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202422:20EDGAR2Form 144 - Report of proposed sale of securities
03.1.202414:03EDGAR2Form 8-K - Current report
03.1.202414:00GLOBECollegium Provides 2024 Financial Guidance
22.12.202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:15EDGAR2Form 144 - Report of proposed sale of securities
20.12.202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202322:28EDGAR2Form 144 - Report of proposed sale of securities
19.12.202322:13EDGAR2Form 144 - Report of proposed sale of securities
18.12.202322:11EDGAR2Form 144 - Report of proposed sale of securities
29.11.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202323:00EDGAR2Form 144 - Report of proposed sale of securities
27.11.202314:00GLOBEAppeals Court Upholds PTAB’s Finding of Invalidity of..
09.11.202314:05EDGAR2Form 8-K - Current report
09.11.202314:00GLOBECollegium Announces $25 Million Accelerated Share Repurchase..
08.11.202314:00GLOBECollegium to Participate in Upcoming Investor Conferences
07.11.202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:01EDGAR2Form 8-K - Current report
07.11.202322:01GLOBECollegium Reports Third Quarter 2023 Financial Results
24.10.202314:00GLOBECollegium to Report Third Quarter 2023 Financial Results on..
28.8.202314:00GLOBECollegium Announces 10 Poster Presentations at PAINWeek..
24.8.202314:05EDGAR2Form 8-K - Current report
24.8.202314:00GLOBECollegium Announces Extension of Nucynta Regulatory..
10.8.202322:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.8.202313:40EDGAR2Form 8-K - Current report
07.8.202313:30GLOBECollegium Announces $50 Million Accelerated Share Repurchase..
03.8.202322:03EDGAR2Form 8-K - Current report
03.8.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:01GLOBECollegium Reports Record 1H’23 Net Revenue of $280.3..
20.7.202314:00GLOBECollegium to Report Second Quarter 2023 Financial Results on..
28.6.202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.6.202314:00GLOBECollegium to Participate in Jefferies Healthcare Conference
04.5.202322:01GLOBECollegium Reports First Quarter 2023 Financial Results

Kürzlich von Ihnen besucht

NASDAQ
COLL
Collegium Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten